Pfizer PFE Earnings Call Transcripts

NYSE PFE

$29.65 +0.19 (+0.66%)

As of: Oct 29, 2026 · 2:30 PM EDT

25 earnings calls on file for Pfizer, from Q4 2019 to Q2 2026. Each transcript opens in a new tab.

Latest earnings call

Pfizer Q2 2026 Earnings Call

Aug 4, 2026 8,292 words · 36 min read

Albert BourlaChairman and Chief Executive Officer
David DentonChief Financial Officer
Cecile GueganIncoming Interim Chief Financial Officer and Executive Vice President
Chris BoshoffChief Scientific Officer

Prepared remarks and the full analyst Q&A, speaker by speaker.

Earnings calls

Calls25

LatestAug 4, 2026

SinceQ4 2019

All 25 Pfizer transcripts Register to get access to Pfizer’s earnings call transcripts.

Pfizer

NYSE: PFE

$29.65 ▲ +0.19 (+0.66%)

Oct 29, 2026 · 2:30 PM EDT